Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378) Announces EGM Poll Results

Bulletin Express

Feb 12

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) held its Extraordinary General Meeting on February 12, 2026, at the company’s conference room in Wuhan, Hubei Province. Shareholders examined and voted by poll on a special resolution to grant a general mandate to the Board to repurchase H Shares.

The total issued share capital entitled to vote consisted of 136.22 million H Shares. The poll results showed 98.77 million votes (99.9996%) in favor, 400 votes (0.0004%) against, and zero abstentions. Since over two-thirds of votes were cast for the resolution, it was duly passed as a special resolution.

According to the announcement, no restrictions were imposed on any shareholders to cast votes, and no shareholders were required to abstain from voting. All directors participated in the EGM either in person or by electronic means, with an appointed scrutineer overseeing the voting process.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1151725131"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151725131\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151725131?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151725131","market":"us","top_or_hot":-1,"title":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378) Announces EGM Poll Results","media":"Bulletin Express","content":"<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) held its Extraordinary General Meeting on February 12, 2026, at the company’s conference room in Wuhan, Hubei Province. Shareholders examined and voted by poll on a special resolution to grant a general mandate to the Board to repurchase H Shares.</p>\n<p>The total issued share capital entitled to vote consisted of 136.22 million H Shares. The poll results showed 98.77 million votes (99.9996%) in favor, 400 votes (0.0004%) against, and zero abstentions. Since over two-thirds of votes were cast for the resolution, it was duly passed as a special resolution.</p>\n<p>According to the announcement, no restrictions were imposed on any shareholders to cast votes, and no shareholders were required to abstain from voting. All directors participated in the EGM either in person or by electronic means, with an appointed scrutineer overseeing the voting process.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378) Announces EGM Poll Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378) Announces EGM Poll Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-12 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) held its Extraordinary General Meeting on February 12, 2026, at the company’s conference room in Wuhan, Hubei Province. Shareholders examined and voted by poll on a special resolution to grant a general mandate to the Board to repurchase H Shares.</p>\n<p>The total issued share capital entitled to vote consisted of 136.22 million H Shares. The poll results showed 98.77 million votes (99.9996%) in favor, 400 votes (0.0004%) against, and zero abstentions. Since over two-thirds of votes were cast for the resolution, it was duly passed as a special resolution.</p>\n<p>According to the announcement, no restrictions were imposed on any shareholders to cast votes, and no shareholders were required to abstain from voting. All directors participated in the EGM either in person or by electronic means, with an appointed scrutineer overseeing the voting process.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03378","symbol_name":"翰思艾泰-B","start_time":0,"source_url":"","article_id":"1151725131","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151725131","pubTimestamp":1770890768,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) held its Extraordinary General Meeting on February 12, 2026, at the company’s conference room in Wuhan, Hubei Province. Shareholders...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03378":"翰思艾泰-B"},"translate_title":"汉克思生物制药（武汉）股份有限公司（3378）公布临时股东大会投票结果","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1},"content_text":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (Stock Code: 3378) held its Extraordinary General Meeting on February 12, 2026, at the company’s conference room in Wuhan, Hubei Province. Shareholders examined and voted by poll on a special resolution to grant a general mandate to the Board to repurchase H Shares.\nThe total issued share capital entitled to vote consisted of 136.22 million H Shares. The poll results showed 98.77 million votes (99.9996%) in favor, 400 votes (0.0004%) against, and zero abstentions. Since over two-thirds of votes were cast for the resolution, it was duly passed as a special resolution.\nAccording to the announcement, no restrictions were imposed on any shareholders to cast votes, and no shareholders were required to abstain from voting. All directors participated in the EGM either in person or by electronic means, with an appointed scrutineer overseeing the voting process.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}